AMERIPRISE FINANCIAL INC - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 167 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q4 2022$267,000
-7.0%
42,951
+0.0%
0.00%
Q3 2022$287,000
+0.3%
42,939
-4.4%
0.00%
Q2 2022$286,000
+232.6%
44,909
+144.1%
0.00%
Q1 2022$86,000
-84.8%
18,399
-83.7%
0.00%
Q4 2021$564,000
+72.5%
112,644
+1782.7%
0.00%
Q1 2020$327,000
-72.6%
5,983
-76.7%
0.00%
-100.0%
Q2 2019$1,193,000
+16.6%
25,640
+0.6%
0.00%
Q1 2019$1,023,000
-13.0%
25,495
-0.3%
0.00%
-100.0%
Q4 2018$1,176,000
+189.7%
25,565
+178.9%
0.00%
Q3 2018$406,000
-73.9%
9,165
-57.3%
0.00%
-100.0%
Q1 2018$1,553,000
-6.5%
21,472
-14.9%
0.00%0.0%
Q4 2017$1,661,000
+33.1%
25,234
+1.3%
0.00%0.0%
Q3 2017$1,248,000
-21.4%
24,913
-27.3%
0.00%0.0%
Q2 2017$1,587,000
+5.9%
34,281
-19.1%
0.00%0.0%
Q1 2017$1,498,000
-8.0%
42,391
+141.0%
0.00%0.0%
Q1 2015$1,629,000
+1.6%
17,587
-55.6%
0.00%0.0%
Q4 2014$1,603,00039,6480.00%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q1 2020
NameSharesValueWeighting ↓
Meditor Group Ltd 4,468,835$22,344,00010.09%
Altium Capital Management LP 2,515,785$12,579,0003.47%
Deep Track Capital, LP 5,641,668$28,208,0001.99%
Paradigm Biocapital Advisors LP 839,257$4,196,0001.20%
SABBY MANAGEMENT, LLC 940,400$4,702,0000.68%
Monaco Asset Management SAM 500,000$2,500,0000.62%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5,000,000$25,000,0000.52%
CVI Holdings, LLC 1,460,595$7,303,0000.48%
PLATINUM INVESTMENT MANAGEMENT LTD 2,713,176$13,566,0000.38%
Rhenman & Partners Asset Management AB 1,000,000$4,960,0000.33%
View complete list of ESPERION THERAPEUTICS INC NE shareholders